Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Novo Nordisk A/S
Recent news which mentions Novo Nordisk A/S
< Previous
1
2
3
4
5
6
7
Next >
Here's why Jim Cramer likes J.M. Smucker's plan to buy the maker of Twinkies
September 11, 2023
Tags
Food and Beverage
Mergers
Eli Lilly and Co
From
CNBC.com News
Ozempic, Wegovy may curb drinking, smoking and other addictive behaviors – here's what we know
September 10, 2023
Tags
Health & Science
Business News
Companies
From
CNBC.com News
Big pharma's blockbuster obesity drug battle is just getting started, and it's headed for $100 billion
September 09, 2023
Tags
CNBC Global CFO Council
Pharmaceuticals
Eli Lilly and Co
From
CNBC.com News
Blockbuster weight loss drugs Wegovy and Ozempic are being tested to treat addiction and dementia
September 07, 2023
Tags
Science
Life Sciences
Eli Lilly and Co
From
CNBC.com News
Stocks making the biggest moves premarket: Enbridge, Roku, Gitlab and more
September 06, 2023
Tags
Economy
Breaking News: Economy
Roku Inc
From
CNBC.com News
Novo Nordisk's Wegovy weight loss drug launches in the UK
September 04, 2023
Tags
Pharmaceuticals
Europe Markets
Health Care Supplies
From
CNBC.com News
Weight loss drugmaker Novo Nordisk vies to become Europe's most valuable company, toppling LVMH
September 01, 2023
Tags
LVMH Moet Hennessy Louis Vuitton SE
Pharmaceuticals
Europe Markets
From
CNBC.com News
5 things to know before the stock market opens Friday
September 01, 2023
Tags
Investment strategy
Lulu's Fashion Lounge Holdings Inc
Economic events
From
CNBC.com News
Ozempic could be the next target of Medicare drug price negotiations – here's why
August 31, 2023
Tags
Pharmaceuticals
Weight management
Business
From
CNBC.com News
Wegovy helps reduce heart failure symptoms in obese people, study says
August 25, 2023
Tags
Health care industry
Biotech and Pharmaceuticals
Novo Nordisk A/S
From
CNBC.com News
Weight loss drugs boost sales at retail pharmacies, but they may not help profits much
August 21, 2023
Tags
Pfizer Inc
Walgreens Boots Alliance Inc
CVS Health Corp
From
CNBC.com News
Weight loss drugs are priced substantially higher in the U.S. than in other countries, analysis says
August 17, 2023
Tags
Business
Pharmaceuticals
Breaking news
From
CNBC.com News
Wegovy could prevent up to 1.5 million heart attacks, strokes over 10 years, study says
August 16, 2023
Tags
Clinical trials
Health care industry
Heart attack
From
CNBC.com News
Novo Nordisk to acquire obesity drug maker Inversago Pharma for up to $1 billion
August 10, 2023
Tags
Health & Science
Business News
Mergers and acquisitions
From
CNBC.com News
Wegovy-maker Novo Nordisk sales soar 30% on strong demand for its weight-loss drug
August 10, 2023
Tags
Novo Nordisk A/S
Europe News
Health & Science
From
CNBC.com News
Insurers face long road, high cost to cover obesity drugs after promising Wegovy heart health data
August 09, 2023
Tags
CVS Health Corp
Weight loss surgery
Medicare health plans
From
CNBC.com News
Obesity drug Wegovy's landmark trial result could 'open up' health insurance access, analyst says
August 09, 2023
Tags
Business News
Drugs
Health & Science
From
CNBC.com News
Stocks making the biggest moves midday: Beyond Meat, Chegg, PNC Financial, Dish & more
August 08, 2023
Tags
M&T Bank Corp
Citizens Financial Group Inc
Goldman Sachs Group Inc
From
CNBC.com News
Stocks making the biggest moves premarket: UPS, Lucid, Beyond Meat, Novo Nordisk and more
August 08, 2023
Tags
Palantir Technologies Inc
Markets
Market Insider
From
CNBC.com News
Eli Lilly says obesity drug helped boost weight loss to 26%, highest seen in late-stage trials
July 27, 2023
Tags
Novo Nordisk A/S
Biotech and Pharmaceuticals
Clinical trials
From
CNBC.com News
UK investigates weight loss, diabetes drugs like Wegovy and Ozempic for suicide risks
July 26, 2023
Tags
Breaking news
Suicides
Sanofi SA
From
CNBC.com News
Weight loss drug Wegovy is from Europe — but users in the region face a long and costly wait
July 26, 2023
Tags
Health & Science
Business News
Drugs
From
CNBC.com News
Eli Lilly to acquire obesity drug maker Versanis for $1.9 billion
July 14, 2023
Tags
Business News
Health & Science
Biotechnology
From
CNBC.com News
Uninsured Americans pay high costs for an insulin Eli Lilly vowed to price at $25, Sen. Warren says
July 13, 2023
Tags
Sanofi SA
Breaking news
Business
From
CNBC.com News
EU expands Wegovy, Ozempic probe over suicide risks to include other weight loss, diabetes drugs
July 11, 2023
Tags
Novo Nordisk A/S
Biotech and Pharmaceuticals
Regulations
From
CNBC.com News
Few patients continue weight loss drugs like Wegovy after a year — but health costs soar for all
July 11, 2023
Tags
Obesity
Breaking news
Business
From
CNBC.com News
Stocks making the biggest moves midday: Shutterstock, Newell Brands, Zillow and more
July 11, 2023
Tags
JPMorgan Chase & Co
Iovance Biotherapeutics Inc
Breaking news
From
CNBC.com News
European regulator to review weight-loss drugs following reports of suicidal thoughts
July 10, 2023
Tags
Pharmaceuticals
Business News
Health Care Supplies
From
CNBC.com News
Moderna strikes deal to develop mRNA drugs in China
July 05, 2023
Tags
Pfizer Inc
Novo Nordisk A/S
Biotech and Pharmaceuticals
From
CNBC.com News
People should stop taking Ozempic, Wegovy obesity drugs before surgery, doctors group says
June 30, 2023
Tags
Weight management
Business
Pharmaceuticals
From
CNBC.com News
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.